Lantern Pharma to Participate and Present at Multiple Upcoming Conferences

On July 17, 2023 Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning ("ML") platform with multiple clinical stage drug programs, reported that the Company will participate and present at four upcoming conferences (Press release, Lantern Pharma, JUL 17, 2023, View Source [SID1234633268]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Biotech CEO Summit USA in La Jolla, CA from July 17-19, 2023. Panna Sharma, Lantern’s CEO and President will be participating.
Conference Website: https://www.biotechceosummit.com

Cancer Molecular Therapeutics Research Association Conference, in Watkins Glen, NY from July 23-27, 2023. Kishor Bhatia Ph.D., Lantern’s Chief Scientific Officer, will be participating, presentation details TBA.
Conference Website/Registration: View Source

Society of Neuro-Oncology/American Society of Clinical Oncology CNS Cancer Conference in San Francisco, CA, on August 10th, 2023 from 5:30-7:30 p.m. PT.
Presentation Title: LP-184, a novel acylfulvene-derived tumor site activated small molecule inhibits adult and pediatric CNS tumor cell growth
Conference Website/Registration:
View Source

International Conference on Drug Conjugates for Directed Therapy in Darmstadt, Germany on Thursday, August 24th, 2023 from 9:45-10:15 a.m. CEST.
Presentation Title: In-silico Approach for the Identification of ADC Targets with Improved Tumor Selectivity
Conference Website/Registration:
View Source

Further details on the data and findings presented at the scientific conferences will be announced following the conference presentations.